Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection

Leukemia. 2021 Mar;35(3):920-923. doi: 10.1038/s41375-021-01175-8. Epub 2021 Feb 19.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 / complications*
  • Female
  • Humans
  • Immunocompromised Host*
  • Lymphoma, Follicular / complications*
  • Middle Aged
  • Recurrence